ARDVRK has Powerful DNA

ARDVRK’s Visionary Team Emerged

from the Life Sciences Industry

Unlike other AR/VR developers who work within many different industries, ARDVRK is relentlessly focused on our sole vision: Better health. Visualized.

We’re uniquely qualified to fulfill that vision. Our entire senior management team has made its mark as commercial and clinical leaders in the life sciences industry.

We are acutely aware of the challenges inherent to building successful brands, drilling down complex science, and measuring evidence and outcomes.

Together, our combined experience enables us to approach medical simulation technology from an insider’s perspective. We know the business…we know the players…and we know what it takes to develop powerful new solutions in clinical and patient education.

ARDVRK Leadership

To make our vision a reality, we’ve assembled an award-winning team of storytellers, engineers, medical specialists, and artists.

Elgar Peerschke CEO & Board Director

Elgar has been on the BOD since 1/1/17 and has over 25 years in healthcare. He has held global leadership positions in the healthcare practices of both McKinsey & Company and Bain & Company. Most recently he was SVP of Customer Relations and President, Advisory Services at IQVIA, a leading clinical research and data organization. Elgar currently works with select healthcare startups and sits on several private company boards.

Mike O’Brien Co-Founder & Head of Product Development

Mike has over 30 years of gaming, film and pharmaceutical industry experience. His past roles include developing ecosystems for gaming analysis; online and direct marketing; and sales for companies such as Viacom, Activision, Paramount, and Nickelodeon. Immediately prior to becoming Chief of Operations at ARDVRK, Mike spent 13 years in sales with AstraZeneca.

Paul Jahn Co-Founder & Chief Medical Officer

Dr. Jahn has nearly 30 years’ experience as a Harvard Medical School Fellowship trained Interventional Radiologist. He has held academic appointments at Harvard Medical School, Monmouth Medical Center, University of Hawaii Medical School, and University of North Dakota Medical School. Dr. Jahn has also served as both the Vice President and President of the North Dakota Medical Association.

Christopher McClellan CTO & XR Software Engineer

Christopher is an AR/VR software engineer with background expertise in 3D application development and visual effects. While studying computer engineering at university, he started Makers Club, an organization fostering students in app development, game development, web development, 3D printing, and prototyping & programming hardware. Applying his lifelong focus in 3D, he now uses the latest advances in mobile AR to pioneer ARDVRK’s Vital Recall® platform.

Tony Lambert, PMP Chief of Staff & Director of Project Management

Tony has over 30 years of successful Project Management experience delivering customer centric products and services across a diverse array of leading edge technologies. As ARDVRK’s Chief of Staff and Project Management, Tony plans and directs administrative, financial and operations tasks with focus on timelines, risk management, product delivery, quality and client relationship management.

ARDVRK Board of Directors

It may seem like a cliché, but at ARDVRK we truly do “leave our egos at the door.” In our ongoing pursuit of new AR and VR solutions, we welcome coaching, mentorship, and insights from our accomplished advisors and board members. We have selected a multi-dimensional team of experts who are not afraid to challenge our ideas and share their own — to ensure everything we do sets the standard for quality and customer satisfaction.

John O’Brien

Co-founder & Chairman

John has over 30 years of experience in the pharmaceutical, biotech, biochemical and life sciences sectors. He recently retired after 23 years of service at AstraZeneca, where he finished his career as Senior Vice President of Portfolio Investments. While at AstraZeneca he also served as VP of Oncology-US, and had P&L responsibility for a $1 billion business unit. In addition, John has held executive positions in international general management, sales and marketing, business development for Amersham International (GE-Biosciences,) and ICI.